CoChat

Sampling for malaria molecular surveillance

Mayor, Alfredo, Ishengoma, Deus S., Proctor, Joshua L., Verity, Robert · 2023 · Trends in Parasitology
Cited by 30

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pt.2023.08.007

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 78

  1. Neafsey, 2021, Advances and opportunities in malaria population genomics, Nat. Rev. Genet., 22, 502, 10.1038/s41576-021-00349-5 · DOI
  2. Tessema, 2019, Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa, Malar. J., 18, 268, 10.1186/s12936-019-2880-1 · DOI
  3. Volkman, 2012, Harnessing genomics and genome biology to understand malaria biology, Nat. Rev. Genet., 13, 315, 10.1038/nrg3187 · DOI
  4. Uwimana, 2020, Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda, Nat. Med., 26, 1602, 10.1038/s41591-020-1005-2 · DOI · Paper page
  5. da Silva, 2023, Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in Mozambique, Commun. Biol., 6, 619, 10.1038/s42003-023-04997-7 · DOI
  6. Chang, 2019, Mapping imported malaria in Bangladesh using parasite genetic and human mobility data, Elife, 8, 10.7554/eLife.43481 · DOI · Paper page
  7. Sturrock, 2015, Tackling imported malaria: an elimination endgame, Am. J. Trop. Med. Hyg., 93, 139, 10.4269/ajtmh.14-0256 · DOI
  8. Taylor, 2017, Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent, PLoS Genet., 13, 10.1371/journal.pgen.1007065 · DOI · Paper page
  9. Archie, 2009, Infecting epidemiology with genetics: a new frontier in disease ecology, Trends Ecol. Evol., 24, 21, 10.1016/j.tree.2008.08.008 · DOI · Paper page
  10. Dalmat, 2019, Use cases for genetic epidemiology in malaria elimination, Malar. J., 18, 163, 10.1186/s12936-019-2784-0 · DOI
  11. Watson, 2021, Evaluating the performance of malaria genetics for inferring changes in transmission intensity using transmission modeling, Mol. Biol. Evol., 38, 274, 10.1093/molbev/msaa225 · DOI
  12. Neafsey, 2015, Genetic diversity and protective efficacy of the RTS,S/AS01 malaria vaccine, N. Engl. J. Med., 373, 2025, 10.1056/NEJMoa1505819 · DOI · Paper page
  13. Rovira-Vallbona, 2021, High proportion of genome-wide homology and increased pretreatment pvcrt levels in Plasmodium vivax late recurrences: a chloroquine therapeutic efficacy study, Antimicrob. Agents Chemother., 65, 10.1128/AAC.00095-21 · DOI
  14. Thawer, 2022, The use of routine health facility data for micro-stratification of malaria risk in mainland Tanzania, Malar. J., 21, 345, 10.1186/s12936-022-04364-7 · DOI
  15. Mitchell, 2022, Evaluating malaria prevalence and land cover across varying transmission intensity in Tanzania using a cross-sectional survey of school-aged children, Malar. J., 21, 80, 10.1186/s12936-022-04107-8 · DOI
  16. Mayor, 2019, Targeting pregnant women for malaria surveillance, Trends Parasitol., 35, 677, 10.1016/j.pt.2019.07.005 · DOI
  17. Kitojo, 2019, Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study, Lancet Glob. Health, 7, e1695, 10.1016/S2214-109X(19)30405-X · DOI · Paper page
  18. Stratton, 2021, Population research: convenience sampling strategies, Prehosp. Disaster Med., 36, 373, 10.1017/S1049023X21000649 · DOI · Paper page
  19. Ehrlich, 2020, Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study, Lancet Microbe, 1, e209, 10.1016/S2666-5247(20)30094-X · DOI
  20. Nsanzabana, 2019, Strengthening surveillance systems for malaria elimination by integrating molecular and genomic data, Trop. Med. Infect. Dis., 4, 10.3390/tropicalmed4040139 · DOI
  21. Gupta, 2017, Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique, Malar. J., 16, 416, 10.1186/s12936-017-2061-z · DOI
  22. Gamboa, 2010, A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests, PLoS One, 5, 10.1371/journal.pone.0008091 · DOI · Paper page
  23. Agaba, 2019, Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010-2019, Malar. J., 18, 355, 10.1186/s12936-019-2987-4 · DOI
  24. Rogier, 2022, Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions from persons with symptomatic malaria infection in Ethiopia, Kenya, Madagascar, and Rwanda, Emerg. Infect. Dis., 28, 608, 10.3201/eid2803.211499 · DOI · Paper page
  25. Plowe, 2015, Vaccine-resistant malaria, N. Engl. J. Med., 373, 2082, 10.1056/NEJMe1511955 · doi:10.1056/nejme1511955
  26. Ikeda, 2018, Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014-2016, Emerg. Infect. Dis., 24, 718, 10.3201/eid2404.170141 · DOI · Paper page
  27. Straimer, 2022, High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine, J. Infect. Dis., 225, 1411, 10.1093/infdis/jiab352 · DOI
  28. Rasmussen, 2022, Current and emerging strategies to combat antimalarial resistance, Expert Rev. Anti Infect. Ther., 20, 353, 10.1080/14787210.2021.1962291 · DOI
  29. Diez Benavente, 2020, A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malaria, PLoS Genet., 16, 10.1371/journal.pgen.1008576 · DOI · Paper page
  30. Obaldia, 2015, Clonal outbreak of Plasmodium falciparum infection in eastern Panama, J. Infect. Dis., 211, 1087, 10.1093/infdis/jiu575 · DOI
  31. de Oliveira, 2020, Population genomics reveals the expansion of highly inbred Plasmodium vivax lineages in the main malaria hotspot of Brazil, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0008808 · DOI
  32. Sy, 2021, Genomic investigation of atypical malaria cases in Kanel, northern Senegal, Malar. J., 20, 103, 10.1186/s12936-021-03637-x · DOI
  33. Galatas, 2016, Malaria parasites in the asymptomatic: looking for the hay in the haystack, Trends Parasitol., 32, 296, 10.1016/j.pt.2015.11.015 · DOI
  34. Early, 2019, Detection of low-density Plasmodium falciparum infections using amplicon deep sequencing, Malar. J., 18, 219, 10.1186/s12936-019-2856-1 · DOI
  35. Pujol, 2023, Detecting temporal and spatial malaria patterns from first antenatal care visits, Res. Sq.
  36. Gonzalez, 2012, HIV and malaria interactions: where do we stand?, Expert Rev. Anti Infect. Ther., 10, 153, 10.1586/eri.11.167 · DOI
  37. Yobi, 2022, Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019, BMC Infect. Dis., 22, 145, 10.1186/s12879-022-07112-z · doi:10.1186/s12879-022-07112-z
  38. Verity, 2020, The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC, Nat. Commun., 11, 2107, 10.1038/s41467-020-15779-8 · DOI
  39. Guillot, 2022, Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: a decision tool, Front. Public Health, 10, 10.3389/fpubh.2022.1003949 · DOI
  40. Racloz, 2006, Sentinel surveillance systems with special focus on vector-borne diseases, Anim. Health Res. Rev., 7, 71, 10.1017/S1466252307001120 · doi:10.1017/s1466252307001120
  41. Blickenstorfer, 2011, Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease, BMC Vet. Res., 7, 49, 10.1186/1746-6148-7-49 · doi:10.1186/1746-6148-7-49
  42. Cameron, 2012, The consequences of risk-based surveillance: developing output-based standards for surveillance to demonstrate freedom from disease, Prev. Vet. Med., 105, 280, 10.1016/j.prevetmed.2012.01.009 · doi:10.1016/j.prevetmed.2012.01.009
  43. Adjah, 2018, Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana, BMC Infect. Dis., 18, 432, 10.1186/s12879-018-3350-z · DOI · Paper page
  44. Kobbe, 2006, Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa, Tropical Med. Int. Health, 11, 613, 10.1111/j.1365-3156.2006.01618.x · DOI
  45. Mayor, 2008, Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants, J. Infect. Dis., 197, 1737, 10.1086/588144 · DOI
  46. Menendez, 2011, HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment, Clin. Infect. Dis., 52, 41, 10.1093/cid/ciq049 · DOI
  47. Brown, 2012, Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies, Malar. J., 11, 333, 10.1186/1475-2875-11-333 · DOI
  48. Sy, 2022, Plasmodium falciparum genomic surveillance reveals spatial and temporal trends, association of genetic and physical distance, and household clustering, Sci. Rep., 12, 938, 10.1038/s41598-021-04572-2 · DOI
  49. Kabaghe, 2017, Adaptive geostatistical sampling enables efficient identification of malaria hotspots in repeated cross-sectional surveys in rural Malawi, PLoS One, 12, 10.1371/journal.pone.0172266 · DOI
  50. Graubard, 1996, Modelling the sampling design in the analysis of health surveys, Stat. Methods Med. Res., 5, 263, 10.1177/096228029600500304 · DOI
  51. Schaffner, 2018, hmmIBD: software to infer pairwise identity by descent between haploid genotypes, Malar. J., 17, 196, 10.1186/s12936-018-2349-7 · DOI · Paper page
  52. Gerlovina, 2022, Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections, Genetics, 222, 10.1093/genetics/iyac126 · DOI · Paper page
  53. Daniels, 2015, Modeling malaria genomics reveals transmission decline and rebound in Senegal, Proc. Natl. Acad. Sci. U. S. A., 112, 7067, 10.1073/pnas.1505691112 · DOI · Paper page
  54. Lee, 2021, Modeling the levels, trends, and connectivity of malaria transmission using genomic data from a health facility in Thiès, Senegal, medRxiv
  55. Nkhoma, 2013, Population genetic correlates of declining transmission in a human pathogen, Mol. Ecol., 22, 273, 10.1111/mec.12099 · DOI · Paper page
  56. Searle, 2017, Distinct parasite populations infect individuals identified through passive and active case detection in a region of declining malaria transmission in southern Zambia, Malar. J., 16, 154, 10.1186/s12936-017-1810-3 · DOI
  57. Sisya, 2015, Subtle changes in Plasmodium falciparum infection complexity following enhanced intervention in Malawi, Acta Trop., 142, 108, 10.1016/j.actatropica.2014.11.008 · doi:10.1016/j.actatropica.2014.11.008
  58. Neafsey, 2017, Malaria genomics in the era of eradication, Cold Spring Harb. Perspect. Med., 7, 10.1101/cshperspect.a025544 · DOI
  59. Nelson, 2019, High-resolution micro-epidemiology of parasite spatial and temporal dynamics in a high malaria transmission setting in Kenya, Nat. Commun., 10, 5615, 10.1038/s41467-019-13578-4 · DOI
  60. Zhu, 2018, The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background, Nat. Commun., 9, 5158, 10.1038/s41467-018-07588-x · DOI
  61. Battle, 2016, Treatment-seeking rates in malaria endemic countries, Malar. J., 15, 20, 10.1186/s12936-015-1048-x · DOI · Paper page
  62. Blasco, 2017, Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic, Nat. Med., 23, 917, 10.1038/nm.4381 · DOI · Paper page
  63. Bushman, 2018, Within-host competition can delay evolution of drug resistance in malaria, PLoS Biol., 16, 10.1371/journal.pbio.2005712 · DOI · Paper page
  64. Griffith, 2020, Collider bias undermines our understanding of COVID-19 disease risk and severity, Nat. Commun., 11, 5749, 10.1038/s41467-020-19478-2 · DOI · Paper page
  65. Zejda, 2021, Seroprevalence of Anti-SARS-CoV-2 antibodies in a random sample of inhabitants of the Katowice Region, Poland, Int. J. Environ. Res. Public Health, 18, 3188, 10.3390/ijerph18063188 · DOI
  66. Lemmen, 2001, Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units, Am. J. Infect. Control, 29, 89, 10.1067/mic.2001.111415 · doi:10.1067/mic.2001.111415
  67. Murato, 2020, Evaluation of sampling methods for effective detection of infected pig farms during a disease outbreak, PLoS One, 15, 10.1371/journal.pone.0241177 · doi:10.1371/journal.pone.0241177
  68. Thompson, 1997, Spatial sampling, CIBA Found. Symp., 210, 161
  69. Salehi, 2021, Adaptive two-stage inverse sampling design to estimate density, abundance, and occupancy of rare and clustered populations, PLoS One, 16, 10.1371/journal.pone.0255256 · doi:10.1371/journal.pone.0255256
  70. Case, 2022, Spatial epidemiology and adaptive targeted sampling to manage the Chagas disease vector Triatoma dimidiata, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010436 · DOI
  71. Andrade-Pacheco, 2020, Finding hotspots: development of an adaptive spatial sampling approach, Sci. Rep., 10, 10939, 10.1038/s41598-020-67666-3 · DOI
  72. Wohl, 2023, Sample size calculations for pathogen variant surveillance in the presence of biological and systematic biases, Cell Rep. Med., 4
  73. Myatt, 2008, A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings, Antivir. Ther., 13, 37, 10.1177/135965350801302S10 · doi:10.1177/135965350801302s10
  74. Ginting, 2019, Rethinking antimicrobial resistance surveillance: a role for lot quality assurance sampling, Am. J. Epidemiol., 188, 734, 10.1093/aje/kwy276 · DOI
  75. Lanata, 1991, Lot quality assurance sampling techniques in health surveys in developing countries: advantages and current constraints, World Health Stat. Q., 44, 133
  76. Hedt, 2012, Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling, Epidemiology, 23, 293, 10.1097/EDE.0b013e3182459455 · doi:10.1097/ede.0b013e3182459455
  77. Smith-Aguasca, 2019, Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by next generation sequencing of Plasmodium falciparum, Malar. J., 18, 351, 10.1186/s12936-019-2946-0 · DOI
  78. Nkemngo, 2022, Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across Cameroon, Gene, 821, 10.1016/j.gene.2022.146339 · DOI

Cited by

Metadata

Authors
Mayor, A., Ishengoma, D. S., Proctor, J. L., & Verity, R.
Venue
Trends in Parasitology
Publisher
Elsevier BV
Published
2023-11
Volume
39
Issue
11
Pages
954-968
ISSN
1471-4922
Cited by
30
References
0
Language
en
Licence
Funders
  • MRC
  • Nigerian Institute of Medical Research
  • Fundación Ramón Areces
  • Foreign, Commonwealth and Development Office
  • Departament d'Universitats, Recerca i Societat de la Informació (2021 SGR 01517)
  • Agencia Española de Cooperación Internacional para el Desarrollo
  • Imperial College London
  • Generalitat de Catalunya
  • Spain Ministry of Science and Innovation
  • United States Agency for International Development
  • Medical Research Council (MR/R015600/1)
  • Bill & Melinda Gates Foundation (INV-031273, INV-019032, INV-002202)
  • European Commission
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (CEX2018-000806-S, MCIN /AEI/10.13039/501100011033)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.